Ir al contenido principal

Receptores de LDL

Los receptores de LDL (o receptores de B/E) constituyen la ruta primaria de remoción de las LDL del plasma.Se considera que el número de recptores de LDL es uno de los principales determinantes de la concentración de LDL en la sangre.Los receptores de LDL son muchos y muy activos al principio de la vida, pero su número y actividad tienden a disminuir con los años. 


LDL receptor (or receptor B / E) is the primary route of clearance of LDL from plasma.Se considered recptores number of LDL is one of the main determinants of the LDL receptors in sangre.Los LDL are many very active at the beginning of life, but their number and activity tend to decrease with age.


低密度脂蛋白受體(或受體B/ E)是從plasma.Se認為recptores的數LDL清除LDL的主要途徑是在sangre.Los的低密度脂蛋白受體的主要決定因素之一LDL有很多非常活躍在生命的開始,但他們的數量和活性隨著年齡的增長趨於下降。

Dī mìdù zhī dànbái shòu tǐ (huò shòu tǐ B/ E) shì cóng plasma.Se rènwéi recptores de shù LDL qīngchú LDL de zhǔyào tújìng shì zài sangre.Los de dī mìdù zhī dànbái shòu tǐ de zhǔyào juédìng yīnsù zhī yī LDL yǒu hěnduō fēicháng huóyuè zài shēngmìng de kāishǐ, dàn tāmen de shùliàng hé huóxìng suízhe niánlíng de zēngzhǎng qū yú xiàjiàng.

Receptor de LDL (receptor ou B / E) é a principal via de depuração do LDL da plasma.Se considerado número recptores de LDL é um dos principais determinantes dos receptores de LDL em sangre.Los LDL são muitas muito activa no início da vida, mas o seu número e a actividade tende a diminuir com a idade.

ЛНП рецептор (рецептор или B / E) является основным маршрутом зазор ЛПНП от plasma.Se считается recptores количество LDL является одним из основных факторов, определяющих рецепторов ЛНП в sangre.Los LDL много очень активны в начале жизни, но их количество и активность имеют тенденцию к снижению с возрастом.

LNP retseptor ( retseptor ili B / E ) yavlyayetsya osnovnym marshrutom zazor LPNP ot plasma.Se schitayetsya recptores kolichestvo LDL yavlyayetsya odnim iz osnovnykh faktorov, opredelyayushchikhretseptorov LNP v sangre.Los LDL mnogo ochen' aktivny v nachale zhizni, no ikh kolichestvo i aktivnost' imeyut tendentsiyu k snizheniyu s vozrastom.

LDL-Rezeptor (Rezeptor oder B / E) ist der erste Weg der Clearance von LDL aus plasma.Se als recptores Anzahl von LDL ist eine der wichtigsten Determinanten der LDL-Rezeptoren in sangre.Los LDL sind viele sehr aktiv am Anfang des Lebens, aber ihre Anzahl und Aktivität neigen dazu, mit zunehmendem Alter abnehmen.



Comentarios

Entradas populares de este blog

dandelion root

dandelion   is used in many traditional and modern herbal medical systems, as you have-been documented Particularly in Asia, Europe, and North America. The root Primarily is Considered a gastrointestinal remedy , supporting digestion and liver function, while the leaf is used as a diuretic and bitter digestive stimulant. Among Dandelions are weeds The most recognizable in the world. Traditional use goes back so far as to predate written records. The leaf of Chinese dandelion (T mongolicum) was first Mentioned in writing in the Tang Materia Medica (659 AD) and is classically Considered a valuable remedy in Chinese medicine, Both topically and internally, for treating abscesses, reducing eye inflammation, and provoking diuresis . Dandelion leaf and root Both Have Been Studied for Their effects on digestion, mostly as bitter digestive stimulants. dandelion root has-been Investigated for demulcent, prebiotic, hypoglycemic, and immune-modulating effects. Dandelio...

The polymerase chain reaction (PCR)

The polymerase chain reaction (PCR) and molecular hybridization were used for detecting and typing human papillomavirus (HPV) in 40 patients with clinical lesions as a control group and in 20 healthy subjects, biopsies on clinically normal oral mucosa. Amplification of HPV DNA was performed using specific oligonucleotide primers: MY09 and MY11 and for typing hybridization was used in plates comprising a mixture of probes of high, intermediate and low oncogenic risk, such as types 2, 4, 6, 11, 13, 16, 18 and 32. The results demonstrated the presence of HPV viral genome in 55 percent (22/40) of benign lesions of the mouth and 10 percent (2/20) in the control group. In oral benign lesions that were positive by PCR, we observed 90.9 percent (20/22) of the type HPV low risk and 9.1 percent (2/22) of HPV and low oncogenic risk lato. In the control group it was detected 5 percent (1/20) of low-risk HPV and 5 percent (1/20) of HPV high and low oncogenic risk.